GCSAM


Summary: This gene encodes a protein which may function in signal transduction pathways and whose expression is elevated in germinal cell lymphomas. It contains a putative PDZ-interacting domain, an immunoreceptor tyrosine-based activation motif (ITAM), and two putative SH2 binding sites. In B cells, its expression is specifically induced by interleukin-4. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008].

NameOMIM IDEnsembl IDHGNC IDPHARMGKB IDMap Location
germinal center associated signaling and motilityMIM:607792Ensembl:ENSG00000174500HGNC:HGNC:20253PA1349805923q13.2

GO terms in GCSAM


Term TypeEvidence TypeGO Term IDGO Des.
BPIMPGO:0050855regulation of B cell receptor signaling pathway
BPIMPGO:2000402negative regulation of lymphocyte migration
CCIEAGO:0005737cytoplasm
CCIEAGO:0005886plasma membrane
MFIPIGO:0003779actin binding
MFIPIGO:0005515protein binding
MFIPIGO:0019901protein kinase binding
MFIPIGO:0045159myosin II binding

Gene expression in normal tissue: GCSAM

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in GCSAM


DatabasePathway IDPathway Des.

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD491TAE-6841
iGMDRD353PD03259011

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in GCSAM

​​​​